Search the Newsreel

Lineage, Inc. (LINE) CFO adds 20,000 shares, lifting indirect IRA stake

Lineage, Inc. CFO Robb A. LeMasters purchased 20,000 shares of the company's common stock on August 7, 2026, at a weighted average price of $41.3319 per share. These shares were acquired indirectly through an IRA, increasing his indirect holdings to 49,500 shares, with an …

1 Healthcare Stock Worth Your Attention and 2 We Ignore

1 Healthcare Stock Worth Your Attention and 2 We Ignore From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 18.3% over …

MaxLinear Introduces Carmel™ High-Speed USB-to-UART Product for Next-Generation AI Data Center Console Access

MaxLinear has launched Carmel™ (MxL81434), a new high-speed USB-to-UART product designed for next-generation AI data centers and hyperscale cloud environments. This solution provides up to 480Mbps USB bandwidth, four UART channels each operating at up to 15Mbps, integrated I²C, and 32 GPIOs for efficient …

MaxLinear, Inc $MXL Shares Acquired by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. significantly increased its stake in MaxLinear, Inc (NASDAQ:MXL) by 110.9% in the second quarter, now owning 221,266 shares valued at $28.33 million. Other institutional investors also adjusted their positions, with notable new purchases and increased holdings. MaxLinear reported strong Q2 …

Should Lineage’s (LINE) Rising Losses on Flat Revenue Prompt a Rethink of Its Profit Strategy?

In the past quarter, Lineage, Inc. reported second-quarter 2026 results showing sales of US$1,361 million versus US$1,350 million a year earlier, while net loss widened to US$29 million and loss per share from continuing operations increased to US$0.13. Over the first six months of …

Lineage Cell Therapeutics Q2 Earnings Call Highlights

Renaissance Technologies LLC Acquires 260,237 Shares of Amneal Pharmaceuticals, Inc. $AMRX

Assenagon Asset Management S.A. Has $42.33 Million Stock Position in Amneal Pharmaceuticals, Inc. $AMRX

Fraser And Neave (SGX:F99) Stock Flat As Margins Strengthen And Sales Slip

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP

Is Lineage (LINE) Fully Valued Following Wider Losses In Its Second Quarter Earnings?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Why Lineage earnings matter for investors now Lineage (LINE) reported second quarter 2026 results on 5 August, with sales of US$1,361 million and a wider …

Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp (NYSE:SBS) Upgraded to "Buy" at Wall Street Zen

Wall Street Zen has upgraded Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp (NYSE:SBS) from "Hold" to "Buy," though the broader analyst consensus remains a "Moderate Buy" with a $183.00 target price. The company recently reported quarterly results that missed expectations, …

Enterprise value to revenue forward of Maui Land & Pineapple Company, Inc. – NYSE:MLP

This article provides financial information for Maui Land & Pineapple Company, Inc. (NYSE: MLP), specifically focusing on its enterprise value to revenue forward. The data is presented within the TradingView platform, indicating various financial metrics and market data sources used for analysis.

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS) Stock News Today

This article provides current stock information for Companhia de Saneamento Basico do Estado de

Notícias das Ações da Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS)

This article provides an overview of the Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS) stock, including its current trading price, market capitalization, and P/E ratio. It directs readers to follow the platform for the latest news, financial results, and …

Noticias de acciones de Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS)

UNICOM Systems Inc. Takes $14.71 Million Position in MaxLinear, Inc $MXL

UNICOM Systems Inc. has acquired a new stake of $14.71 million in MaxLinear, Inc (NASDAQ:MXL), purchasing 114,900 shares and making it 1% of its portfolio. MaxLinear, a semiconductor company, is heavily owned by institutional investors (90.79%) and has seen mixed but improving analyst sentiment, …

First Trust Advisors LP Has $3.39 Million Holdings in Lineage, Inc. $LINE

First Trust Advisors LP significantly increased its stake in Lineage, Inc. (NASDAQ:LINE) by 1,328.8% in the first quarter, now holding 103,602 shares valued at $3.39 million. Other institutional investors like Norges Bank and Morgan Stanley also accumulated substantial positions. Lineage, which recently paid a …

Lineage Cell Therapeutics (LCTX) Stock Faces Cash Burn Despite Paper Profit

State Street Corporation (NASDAQ: MXL) reports 4.8% beneficial stake in MaxLinear

State Street Corporation has reported a passive ownership of 4.8% in MaxLinear Inc. common stock, amounting to 4,325,471 shares. This stake, held across various State Street Global Advisors entities, includes shared voting power over 4,100,658 shares and shared dispositive power over all 4,325,471 shares, …

Fraser & Neave Lifts Earnings on Margin Gains Despite Revenue Drop and Market Headwinds

Lineage, Inc. $LINE Shares Bought by Bank of America Corp DE

Bank of America Corp DE significantly increased its stake in Lineage, Inc. by 712.1% in the first quarter, acquiring over 3.17 million additional shares. Despite this large acquisition, analysts maintain a cautious "Hold" rating for Lineage, with an average price target of $43.62, close …

Amneal (AMRX) Upgraded to Buy: What Does It Mean for the Stock?

Amneal Pharmaceuticals (AMRX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. The Zacks …

Lineage Cell Therapeutics Inc (LCTX) Stock News Today

Is ACADIA Pharmaceuticals (ACAD) Outperforming Other Medical Stocks This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Acadia Pharmaceuticals (ACAD) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a …

Amneal Pharmaceuticals' (NASDAQ:AMRX) Strong Earnings Are Of Good Quality

Amneal Pharmaceuticals reported healthy earnings, but the stock price remained stable. The company's profit was impacted by US$81m in unusual expenses, which are likely one-off events, suggesting higher future profits. The article highlights that these unusual items might cause Amneal Pharmaceuticals' statutory profit to …

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Maui Land & Pineapple (NYSE:MLP) Shares Cross Above 200 Day Moving Average - Here's Why

Lineage Cell Therapeutics Inc (LCTX) (Q2 2026) Earnings Call Highlights: Cash Runway Extended, ...

Lineage Cell Therapeutics Inc (LCTX) reported its Q2 2026 earnings, highlighting an extended cash runway into Q3 2028 and a net income of $1.5 million due to non-cash gains. While several programs like Alascope and ILT1 are advancing, the company faces challenges including decreased …

Fraser and Neave reports 9MFY2026 earnings of $177.1 mil, 4.5% higher y-o-y

Court Grants Final Order Approving Acquisition of Kneat by Thoma Bravo

LIMERICK, Ireland, Aug. 06, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), (“Kneat” or the “Company”), the global leader in digital validation and quality process automation, today announced that the Ontario Superior Court of Justice (Commercial List) has issued a final order …

MaxLinear, Inc (MXL) Stock forecasts

Argus has raised its target price for MaxLinear, Inc (MXL) stock to $76.00, up from the current price of $68.44. MaxLinear is a provider of radio frequency and mixed-signal integrated circuits for various communication and networking applications. The report was issued on August 5, …

[10-Q] Lineage Cell Therapeutics, Inc. Quarterly Earnings Report

Lineage says it will spend up to $100 million on Boyle Heights cleanup as air regulators demand action

Lineage Logistics announced it expects to spend between $80 million and $100 million on the cleanup of its Boyle Heights cold storage facility, which caught fire in June and has since generated over 4,000 odor complaints. Air quality regulators are demanding legal action, pushing …

FMR LLC (MXL) files Schedule 13G/A showing 1.8% MaxLinear ownership

FMR LLC and Abigail P. Johnson have filed a Schedule 13G/A to update their passive investment in MaxLinear Inc. FMR LLC now beneficially owns 1,650,823.96 shares, representing 1.8% of the common stock, with sole voting power over 1,648,630 shares and sole dispositive power over …

Air quality board to hear from Lineage officials on warehouse cleanup

The South Coast Air Quality Management District board is holding a two-day meeting to consider an abatement order against Lineage Logistics regarding the cleanup of its Boyle Heights warehouse after a June 17 fire. Residents have reported strong odors and health concerns, leading to …